Unia Europejska - duński - EMA (European Medicines Agency)

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiske - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Unia Europejska - duński - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiske - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - tapentadolhydrochlorid - depottabletter - 50 mg

Unia Europejska - duński - EMA (European Medicines Agency)

eli lilly nederland b.v. - duloxetin - diabetiske neuropatier - psychoanaleptics, - behandling af diabetisk perifer neuropatisk smerte. ariclaim er indiceret hos voksne.

Unia Europejska - duński - EMA (European Medicines Agency)

merck sharp and dohme b.v - ribavirin - hepatitis c kronisk - antivirals for systemic use, antivirals for treatment of hcv infections - rebetol er indiceret i kombination med andre lægemidler til behandling af kronisk hepatitis c (chc) hos voksne. rebetol er indiceret i kombination med andre lægemidler til behandling af kronisk hepatitis c (chc) for pædiatriske patienter (børn fra 3 år og ældre og unge), der ikke tidligere er behandlet, og uden leveren dekompensation.

Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - ciprofloxacinhydrochlorid, vandfrit - filmovertrukne tabletter - 250 mg

Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

fresenius kabi ab - ciprofloxacin - infusionsvæske, opløsning - 2 mg/ml

Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

hexal a/s - ciprofloxacin - filmovertrukne tabletter - 250 mg

Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

krka sverige ab - ciprofloxacinhydrochlorid (monohydrat) - filmovertrukne tabletter - 250 mg

Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - ciprofloxacinhydrochlorid, vandfrit - filmovertrukne tabletter - 250 mg